Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
16 Sep 24 | MBX MBX Biosciences, Inc. Common Stock | Common Stock | Buy | Acquire P | No | No | 16 | 625,000 | 10.00 mm | 4,552,774 |
16 Sep 24 | MBX MBX Biosciences, Inc. Common Stock | Common Stock | Conversion | Acquire C | No | No | 0 | 3,927,774 | 0.00 | 3,927,774 |
16 Sep 24 | MBX MBX Biosciences, Inc. Common Stock | Series B Convertible Preferred Stock Common Stock | Conversion | Dispose C | No | No | 0 | 28,297,265 | 0.00 | 0 |
16 Sep 24 | MBX MBX Biosciences, Inc. Common Stock | Series A Convertible Preferred Stock Common Stock | Conversion | Dispose C | No | No | 0 | 18,922,852 | 0.00 | 0 |
23 May 24 | PHAT Phathom Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 10,500 | 0.00 | 32,096 |
23 May 24 | PHAT Phathom Pharmaceuticals | Stock Option Common Stock | Grant | Dispose A | No | No | 10.3 | 17,500 | 180.25 k | 17,500 |
20 May 24 | ALPN Alpine Immune Sciences | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 19 | 17,500 | 332.50 k | 0 |
20 May 24 | ALPN Alpine Immune Sciences | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 7.43 | 10,000 | 74.30 k | 0 |
20 May 24 | ALPN Alpine Immune Sciences | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 13.89 | 10,000 | 138.90 k | 0 |
20 May 24 | ALPN Alpine Immune Sciences | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 13.45 | 7,650 | 102.89 k | 0 |